Correlates of uptake of optimal doses of sulfadoxine‑pyrimethamine for prevention of malaria during pregnancy in East‑Central Uganda

Simple item page
dc.contributor.authorMbonye, K. Martin
dc.contributor.authorKirwana, B. Venantius
dc.contributor.authorNdugga, Patricia
dc.contributor.authorKikaire, Bernard
dc.contributor.authorBaleeta, Keith
dc.contributor.authorKabagenyi, Allen
dc.contributor.authorAsiimwe, Godfrey
dc.contributor.authorTwesigye, Rogers
dc.contributor.authorKadengye T., Damazo
dc.contributor.authorDathan, Byonanebye M.
dc.date.accessioned2022-10-30T11:13:01Z
dc.date.available2022-10-30T11:13:01Z
dc.date.issued2020
dc.description.abstractIn 2012, the World Health Organization recommended that pregnant women in malaria-endemic countries complete at least three (optimal) doses of intermittent preventive treatment (IPTp) using sulfadoxinepyrimethamine (SP) to prevent malaria and related adverse events during pregnancy. Uganda adopted this recommendation, but uptake remains low in East-Central and information to explain this low uptake remains scanty. This analysis determined correlates of uptake of optimal doses of IPTp-SP in East-Central Uganda. Methods: This was a secondary analysis of the 2016 Uganda Demographic Health Survey data on 579 women (15–49 years) who attended at least one antenatal care (ANC) visit and had a live birth within 2 years preceding the survey. Uptake of IPTp-SP was defined as optimal if a woman received at least three doses; partial if they received 1–2 doses or none if they received no dose. Multivariate analysis using multinomial logistic regression was used to determine correlates of IPTp-SP uptake. Results: Overall, 22.3% of women received optimal doses of IPTp-SP, 48.2% partial and 29.5% none. Attending ANC at a lower-level health centre relative to a hospital was associated with reduced likelihood of receiving optimal doses of IPTp-SP. Belonging to other religious faiths relative to Catholic, belonging to a household in the middle relative to poorest wealth index, and age 30 and above years relative to 25–29 years were associated with higher likelihood of receiving optimal doses of IPTp-SP. Conclusions: In East-Central Uganda, uptake of optimal doses of IPTp-SP is very low. Improving institutional delivery and household wealth, involving religious leaders in programmes to improve uptake of IPTp-SP, and strengthening IPTp-SP activities at lower level health centers may improve uptake of IPTp-SP in the East-Central Uganda.en_US
dc.identifier.citationMartin, M. K., Venantius, K. B., Patricia, N., Bernard, K., Keith, B., Allen, K., ... & Dathan, B. M. (2020). Correlates of uptake of optimal doses of sulfadoxine-pyrimethamine for prevention of malaria during pregnancy in East-Central Uganda. Malaria Journal, 19(1), 1-14. https://doi.org/10.1186/s12936-020-03230-8en_US
dc.identifier.urihttps://doi.org/10.1186/s12936-020-03230-8
dc.identifier.urihttps://nru.uncst.go.ug/handle/123456789/5030
dc.language.isoenen_US
dc.publisherMalaria Journalen_US
dc.subjectIntermittent preventive treatment during pregnancyen_US
dc.subjectMalariaen_US
dc.subjectUgandaen_US
dc.subjectDemographic and health surveyen_US
dc.titleCorrelates of uptake of optimal doses of sulfadoxine‑pyrimethamine for prevention of malaria during pregnancy in East‑Central Ugandaen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Correlates of uptake of optimal doses.pdf
Size:
1.04 MB
Format:
Adobe Portable Document Format
Description:
Article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical and Health Sciences